We may be steps closer to preventing some to the effects of Parkinson's Disease with the help of a Florida A&M University researcher.
Professor Nazarius Lamango with FAMU's College of Pharmacy is working with a team of researchers to develop a compound that blocks various affects of Parkinson's Disease such as tremors and hypokinesia.
FAMU has an exclusive license with Signum Biosciences, with the hope Signum will be able to develop therapeutics based on Lamango's research.
"What we are seeing in animals will hopefully for us to come up with compounds that will hopefully be used for drugs in the future," says Lamango.
Lamango's research is supported by the National Institutes of Health.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.